Projects funded by the NCN
Pharmacogenetics in predicting metabolic ratio of tamoxifen; genome-wide association study linked to mass spectrometry-based analyses
2011/01/B/NZ2/05374
Keywords:
tamoxifen breast cancer polymorphism association studies mass spectrometry
Descriptors:
- NZ2_1: Molecular genetics
- NZ2_2: Genomics, transcriptomics, epigenomics
- NZ2_3: Proteomics
Panel:
NZ2 - Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology
Host institution :
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 12
Call: OPUS 1 - announced on 2011-03-15
Amount awarded: 648 000 PLN
Project start date (Y-m-d): 2011-12-12
Project end date (Y-m-d): 2014-12-11
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Information in the final report
- Publication in academic press/journals (2)
- Common low-penetrance risk variants associated with breast cancer in Polish womenAuthors:Ledwoń JK, Hennig EE*, Maryan N, Goryca K, Nowakowska D, Niwińska A, Ostrowski JAcademic press:BMC Cancer (rok: 2013, tom: 0,895833333333333, strony: 45300), Wydawca: BioMedCentralStatus:PublishedDOI:10.1186/1471-2407-13-510 - link to the publication
- Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancerAuthors:Hennig EE*, Piatkowska M, Karczmarski J, Goryca K, Brewczynska E, Jazwiec R, Kluska A, Omiotek R, Paziewska A, Dadlez M, Ostrowski J.Academic press:BMC Cancer (rok: 2015, tom: 1,02083333333333, strony: 45303), Wydawca: BioMed CentralStatus:PublishedDOI:10.1186/s12885-015-1575-4 - link to the publication